Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Králíčková M, Laganà AS, Ghezzi F, Vetvicka V (2020) Endometriosis and risk of ovarian cancer: what do we know? Arch Gynecol Obstet 301(1):1–10
2. Liu S, Gao S, Wang XY, Wang DB (2012) Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Arch Gynecol Obstet 285(4):1065–1072
3. Zhang Y, Qin X, Jiang J, Zhao W (2020) MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett 20(2):1327–1335
4. Guo T, Yuan D, Lin M, Zhu D, Xu N, Wang J (2020) Aberrant expression of ADAM9 in ovarian cancer and its clinical significance. J Clin Lab Anal 34(4):e23136
5. Hua Y, Liang C, Miao C, Wang S, Su S, Shao P, Liu B, Bao M, Zhu J, Xu A, Zhang J, Li J, Wang Z (2018) MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncol Lett 15(6):9051–9060